Balchem Corporation (BCPC) - Total Assets
Based on the latest financial reports, Balchem Corporation (BCPC) holds total assets worth $1.71 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Balchem Corporation book value and equity for net asset value and shareholders' equity analysis.
Balchem Corporation - Total Assets Trend (1985–2025)
This chart illustrates how Balchem Corporation's total assets have evolved over time, based on quarterly financial data.
Balchem Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
Balchem Corporation's total assets of $1.71 Billion consist of 21.4% current assets and 78.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.4% |
| Accounts Receivable | $143.60 Million | 8.4% |
| Inventory | $131.45 Million | 7.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $163.29 Million | 9.6% |
| Goodwill | $816.38 Million | 47.8% |
Asset Composition Trend (1985–2025)
This chart illustrates how Balchem Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Balchem Corporation (BCPC) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Balchem Corporation's current assets represent 21.4% of total assets in 2025, a decrease from 38.9% in 1985.
- Cash Position: Cash and equivalents constituted 4.4% of total assets in 2025, up from 0.0% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 56.0% of total assets, an increase from 0.0% in 1985.
- Asset Diversification: The largest asset category is goodwill at 47.8% of total assets.
Balchem Corporation Competitors by Total Assets
Key competitors of Balchem Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP
|
Germany | €13.95 Billion |
|
Akzo Nobel NV
AS:AKZA
|
Netherlands | €13.95 Billion |
|
Jiangsu Nata Opto Electr Material
SHE:300346
|
China | CN¥6.27 Billion |
|
Huaibei Mining Holdings Co Ltd
SHG:600985
|
China | CN¥89.26 Billion |
|
Incitec Pivot Ltd
AU:IPL
|
Australia | AU$8.40 Billion |
|
Wankai New Materials Co. Ltd.
SHE:301216
|
China | CN¥17.84 Billion |
|
5N Plus Inc.
TO:VNP
|
Canada | CA$474.27 Million |
|
Longkou Union Chemical Co. Ltd. A
SHE:301209
|
China | CN¥968.45 Million |
Balchem Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.07 | 1.99 | 3.17 |
| Quick Ratio | 1.33 | 1.16 | 2.30 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $189.23 Million | $156.09 Million | $192.44 Million |
Balchem Corporation - Advanced Valuation Insights
This section examines the relationship between Balchem Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.40 |
| Latest Market Cap to Assets Ratio | 3.03 |
| Asset Growth Rate (YoY) | 8.4% |
| Total Assets | $1.71 Billion |
| Market Capitalization | $5.17 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Balchem Corporation's assets at a significant premium (3.03x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Balchem Corporation's assets grew by 8.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Balchem Corporation (1985–2025)
The table below shows the annual total assets of Balchem Corporation from 1985 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $1.71 Billion | +8.39% |
| 2024-12-31 | $1.58 Billion | -1.37% |
| 2023-12-31 | $1.60 Billion | -1.68% |
| 2022-12-31 | $1.62 Billion | +35.45% |
| 2021-12-31 | $1.20 Billion | +2.87% |
| 2020-12-31 | $1.17 Billion | +0.88% |
| 2019-12-31 | $1.16 Billion | +17.76% |
| 2018-12-31 | $981.36 Million | +1.84% |
| 2017-12-31 | $963.64 Million | +1.58% |
| 2016-12-31 | $948.63 Million | +7.65% |
| 2015-12-31 | $881.22 Million | +2.32% |
| 2014-12-31 | $861.27 Million | +128.53% |
| 2013-12-31 | $376.87 Million | +20.58% |
| 2012-12-31 | $312.55 Million | +15.03% |
| 2011-12-31 | $271.72 Million | +18.85% |
| 2010-12-31 | $228.62 Million | +21.73% |
| 2009-12-31 | $187.81 Million | +21.58% |
| 2008-12-31 | $154.47 Million | +0.03% |
| 2007-12-31 | $154.42 Million | +67.25% |
| 2006-12-31 | $92.33 Million | +22.88% |
| 2005-12-31 | $75.14 Million | +24.40% |
| 2004-12-31 | $60.41 Million | +6.15% |
| 2003-12-31 | $56.91 Million | +6.77% |
| 2002-12-31 | $53.30 Million | +19.83% |
| 2001-12-31 | $44.48 Million | +91.53% |
| 2000-12-31 | $23.22 Million | +5.55% |
| 1999-12-31 | $22.00 Million | -2.65% |
| 1998-12-31 | $22.60 Million | +28.41% |
| 1997-12-31 | $17.60 Million | +16.56% |
| 1996-12-31 | $15.10 Million | +5.59% |
| 1995-12-31 | $14.30 Million | +16.26% |
| 1994-12-31 | $12.30 Million | +33.70% |
| 1993-12-31 | $9.20 Million | +21.05% |
| 1992-12-31 | $7.60 Million | 0.00% |
| 1991-12-31 | $7.60 Million | +26.67% |
| 1990-12-31 | $6.00 Million | +9.09% |
| 1989-12-31 | $5.50 Million | -5.17% |
| 1988-12-31 | $5.80 Million | +20.83% |
| 1987-12-31 | $4.80 Million | +26.32% |
| 1986-12-31 | $3.80 Million | +5.56% |
| 1985-12-31 | $3.60 Million | -- |
About Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment… Read more